FRANCISCO GAYTAN LUNA2026-01-292026-01-29201410.1016/j.fertnstert.2014.01.0312-s2.0-84899896674https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/25369Obstetrics and GynecologyReproductive MedicineObstetrics and GynecologyReproductive MedicineDopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: Implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonistsresearch article